EE200400043A - Uudsed heterotsüklilised ühendid kui selektiivsedbakteriaalsed DHFR inhibiitorid ning nende kasutamine - Google Patents

Uudsed heterotsüklilised ühendid kui selektiivsedbakteriaalsed DHFR inhibiitorid ning nende kasutamine

Info

Publication number
EE200400043A
EE200400043A EEP200400043A EEP200400043A EE200400043A EE 200400043 A EE200400043 A EE 200400043A EE P200400043 A EEP200400043 A EE P200400043A EE P200400043 A EEP200400043 A EE P200400043A EE 200400043 A EE200400043 A EE 200400043A
Authority
EE
Estonia
Prior art keywords
heterocyclic compounds
novel heterocyclic
dhfr inhibitors
bacterial dhfr
selective bacterial
Prior art date
Application number
EEP200400043A
Other languages
English (en)
Estonian (et)
Inventor
T. Moe Scott
J. Clement Jacob
H. Faerman Carlos
Perola Emanuele
A. Navia Manuel
J. Ala Paul
S. Magee Andrew
M. Will Paul
A. Marchese Salvatore
V. Gazzaniga John
Original Assignee
Essential Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Essential Therapeutics, Inc. filed Critical Essential Therapeutics, Inc.
Publication of EE200400043A publication Critical patent/EE200400043A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EEP200400043A 2001-06-28 2002-06-28 Uudsed heterotsüklilised ühendid kui selektiivsedbakteriaalsed DHFR inhibiitorid ning nende kasutamine EE200400043A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30168501P 2001-06-28 2001-06-28
PCT/US2002/020479 WO2003002064A2 (en) 2001-06-28 2002-06-28 Fused pyrimidine dhfr inhibitors as antibacterials

Publications (1)

Publication Number Publication Date
EE200400043A true EE200400043A (et) 2004-10-15

Family

ID=23164426

Family Applications (2)

Application Number Title Priority Date Filing Date
EEP200400043A EE200400043A (et) 2001-06-28 2002-06-28 Uudsed heterotsüklilised ühendid kui selektiivsedbakteriaalsed DHFR inhibiitorid ning nende kasutamine
EEP200400042A EE200400042A (et) 2001-06-28 2002-06-28 8/17 heterotsüklilised ühendid ning nende kasutamine D-alanüül-D-alaniini ligaasi inhibiitoritena

Family Applications After (1)

Application Number Title Priority Date Filing Date
EEP200400042A EE200400042A (et) 2001-06-28 2002-06-28 8/17 heterotsüklilised ühendid ning nende kasutamine D-alanüül-D-alaniini ligaasi inhibiitoritena

Country Status (16)

Country Link
US (3) US20030176436A1 (pl)
EP (2) EP1432713A4 (pl)
CN (2) CN1547472A (pl)
BG (1) BG108548A (pl)
BR (1) BR0211310A (pl)
CA (2) CA2451840A1 (pl)
CZ (2) CZ200442A3 (pl)
EA (1) EA200400094A1 (pl)
EE (2) EE200400043A (pl)
HU (2) HUP0700040A2 (pl)
IL (2) IL159538A0 (pl)
MX (1) MXPA04000159A (pl)
PL (2) PL374259A1 (pl)
SK (1) SK302004A3 (pl)
WO (2) WO2003001887A2 (pl)
YU (2) YU102503A (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0217703D0 (en) * 2002-07-31 2002-09-11 Univ Liverpool Pharmaceutical composition
JP2008519083A (ja) * 2004-11-09 2008-06-05 エフ．ホフマン−ラ ロシュ アーゲー アミノキナゾリン化合物
WO2007009911A1 (en) * 2005-07-21 2007-01-25 F. Hoffmann-La Roche Ag PYRIDO [2 , 3-D] PYRIMIDINE-2 , 4-DIAMINE COMPOUNDS AS PTPlB INHIBITORS
GB0608822D0 (en) * 2006-05-04 2006-06-14 Chroma Therapeutics Ltd Inhibitors of DHFR
SI22338A (sl) * 2006-08-18 2008-02-29 Univerza V Ljubljani, Fakulteta Za Farmacijo Diazendikarboksamidi kot inhibitorji d-alanil-d-alanin ligaze
TW200831528A (en) 2006-11-30 2008-08-01 Astrazeneca Ab Compounds
CN101084901B (zh) * 2007-06-22 2011-12-21 复旦大学 一种葡萄球菌抑制剂
US8071766B2 (en) * 2008-02-01 2011-12-06 Takeda Pharmaceutical Company Limited HSP90 inhibitors
DE112010001212T5 (de) * 2009-03-20 2012-07-05 The Board Of Regents Of The University Of Texas System Verfahren, urn einem medizinischen Gerät antimikrobielle Aktivität zu verleihen
KR20120073215A (ko) * 2009-08-31 2012-07-04 다우 아그로사이언시즈 엘엘씨 프테리딘 및 그의 농약으로서의 용도
DK3097102T3 (en) 2015-03-04 2018-01-22 Gilead Sciences Inc TOLL-LIKE RECEPTOR MODULATING 4,6-DIAMINO-PYRIDO [3,2-D] PYRIMIDINE COMPOUNDS
CN106316966A (zh) * 2015-06-15 2017-01-11 董运勤 医药中间体n-(2-吡嗪甲基)苄胺磷酸盐化合物制备方法
MA46093A (fr) 2016-09-02 2021-05-19 Gilead Sciences Inc Composés modulateurs du recepteur de type toll
WO2018045150A1 (en) 2016-09-02 2018-03-08 Gilead Sciences, Inc. 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
TWI716668B (zh) 2017-02-01 2021-01-21 耶魯大學 心臟衰竭及心腎症候群之精準治療
MX2020006882A (es) 2018-01-05 2020-09-07 Novo Nordisk As Metodos para tratar inflamacion mediada por interleucina-6 sin inmunosupresion.
EP3917914A1 (en) * 2019-02-01 2021-12-08 Fmc Corporation Diamino-substituted pyridines and pyrimidines as herbicides
TW202212339A (zh) 2019-04-17 2022-04-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202210480A (zh) 2019-04-17 2022-03-16 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI879779B (zh) 2019-06-28 2025-04-11 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法
GB2626567A (en) * 2023-01-26 2024-07-31 De Montfort Univ Quinazoline derivatives for use as a medicament

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2949466A (en) * 1958-03-04 1960-08-16 Parke Davis & Co Pyrimidine compounds and means of producing the same
US3134778A (en) * 1963-08-20 1964-05-26 Smith Kline French Lab 2,5,7-triamino-4-phenyl (or thienyl)-pyrimido[4,5-d]pyrimidines
RO56210A2 (pl) 1970-12-28 1974-08-01
US4079056A (en) * 1975-03-31 1978-03-14 The United States Of America As Represented By The Department Of Health, Education And Welfare Method of making pteridine compounds
DE2750288A1 (de) * 1977-11-10 1979-05-17 Thomae Gmbh Dr K Neue 9-(omega-heteroarylamino- alkylamino)-erythromycine, ihre salze, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3445298A1 (de) 1984-12-12 1986-06-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue pteridine, verfahren zu ihrer herstellung und deren verwendung als zwischenprodukte oder als arzneimittel
WO1992017478A1 (en) 1991-04-08 1992-10-15 Duquesne University Of The Holy Ghost 5-ALKYL-6-[[AMINO]METHYL]PYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AND METHODS OF PREPARING AND USING THESE DERIVATIVES
US5547954A (en) 1994-05-26 1996-08-20 Fmc Corporation 2,4-Diamino-5,6-disubstituted-and 5,6,7-trisubstituted-5-deazapteridines as insecticides
ATE252100T1 (de) * 1995-02-27 2003-11-15 Hoffmann La Roche Dioxopyrrolo-pyrrolderivate
AU2960599A (en) 1998-03-30 1999-10-18 Akira Karasawa Quinazoline derivatives
JP2000239277A (ja) 1999-02-19 2000-09-05 Kyowa Hakko Kogyo Co Ltd イミダゾキナゾリン誘導体
GB0219893D0 (en) 2002-08-27 2002-10-02 Melacure Therapeutics Ab Pharmaceutically active compounds

Also Published As

Publication number Publication date
EE200400042A (et) 2004-10-15
IL159540A0 (en) 2004-06-01
BR0211310A (pt) 2006-10-31
HUP0700061A2 (en) 2007-05-02
BG108548A (bg) 2005-05-31
US20030181470A1 (en) 2003-09-25
US20080090847A1 (en) 2008-04-17
US7345048B2 (en) 2008-03-18
EP1411949A4 (en) 2004-11-24
EP1432713A2 (en) 2004-06-30
HUP0700040A2 (en) 2007-05-29
SK302004A3 (sk) 2005-07-01
CA2451840A1 (en) 2003-01-09
WO2003001887A3 (en) 2003-08-21
WO2003001887A2 (en) 2003-01-09
YU102503A (sh) 2006-08-17
PL374589A1 (pl) 2005-10-31
IL159538A0 (en) 2004-06-01
WO2003002064A3 (en) 2003-10-23
EA200400094A1 (ru) 2005-08-25
WO2003002064A2 (en) 2003-01-09
PL374259A1 (pl) 2005-10-03
US20030176436A1 (en) 2003-09-18
EP1411949A2 (en) 2004-04-28
CN1543465A (zh) 2004-11-03
YU102303A (sh) 2006-08-17
CN1547472A (zh) 2004-11-17
MXPA04000159A (es) 2005-01-07
EP1432713A4 (en) 2005-05-11
CZ200443A3 (cs) 2004-08-18
CZ200442A3 (cs) 2004-10-13
CA2451800A1 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
EE200300325A (et) Asendatud amiini derivaadid ning nende kasutamismeetodid
DE60317799D1 (de) Antimikrobielle zusammensetzung und anwendungsverfahren
IL157659A0 (en) New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
PL374259A1 (pl) Nowe związki heterocykliczne jako selektywne inhibitory bakteryjnej DHRF oraz ich zastosowanie
EE200300281A (et) Fumaarhappe derivaadid kui NF-kappaB inhibiitorid
EE200300384A (et) Kinasoliinid kui MMP-13 inhibiitorid
IS6656A (is) Útskiptar kínasólínafleiður og notkun þeirra sem hemla
LTPA2011012I1 (lt) Laktamą turintys junginiai ir jų dariniai kaip xa faktoriaus inhibitoriai
EE200200237A (et) Kinasoliini derivaadid kui VEGF-i inhibiitorid
NL1027811A1 (nl) Heterocyclische aminen als remmers 11- -hydroxy-steroïd-dehydrogenase type 1.
IL161258A0 (en) Heterocyclic compounds and methods of use
DE60132732D1 (de) Primerzusammensetzung und Verbindungsverfahren
ATE390426T1 (de) Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate
IL173986A0 (en) 2-pyridone derivatives as netrophil elastase inhibitors and their use
DE60332396D1 (de) PYRAZOLOi3,4-B PYRIDINVERBINDUNGEN UND IHRE VERWENDUNG ALS PHOSPHODIESTERASE INHIBITOREN
ATE333463T1 (de) Selektive dipeptidische inhibitoren von kallikrein
DK1471902T3 (da) Sammensætninger til brug i fremgangsmåder til behandling af høretab
IL169336A0 (en) Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
EE200300266A (et) Asendatud 8-arüülkinoliinid kui fosfodiesteraas-4inhibiitorid
ATE382040T1 (de) Acylaminothiazolderivate und ihre vewrendung als beta-amyloid inhibitoren
DE60217870D1 (de) Verwendung von 2- 5-(4-fluorphenyl)-3-pyridylmethylaminomethyl-chroman und seiner physiologisch annehmbaren salze
FI20011778A0 (fi) Ryhmälähetyksen toteutus
IL169337A0 (en) Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
EP1687632A4 (en) Plks as modifiers of the beta catenin pathway and methods of use
SE0102175D0 (sv) Composition and potentiating method